Adele Chimento
Overview
Explore the profile of Adele Chimento including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giordano F, DAmico M, Montalto F, Malivindi R, Chimento A, Conforti F, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373242
Glioblastoma multiforme (GBM) is one of the most aggressive types of cancer characterized by poor patient outcomes. To date, it is believed that the major cause of its recurrence and...
2.
Chimento A, DAmico M, De Luca A, Conforti F, Pezzi V, De Amicis F
Life (Basel)
. 2023 Feb;
13(2).
PMID: 36836619
Plant-derived bioactive compounds are gaining wide attention for their multiple health-promoting activities and in particular for their anti-cancer properties. Several studies have highlighted how they can prevent cancer initiation and...
3.
Nocito M, Avena P, Zavaglia L, De Luca A, Chimento A, Hamad T, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831394
Extensive research suggests that curcumin interferes with multiple cell signaling pathways involved in cancer development and progression. This study aimed to evaluate curcumin effects on adrenocortical carcinoma (ACC), a rare...
4.
Chimento A, De Luca A, DAmico M, De Amicis F, Pezzi V
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675194
Various literature data show how a diet rich in vegetables could reduce the incidence of several cancers due to the contribution of the natural polyphenols contained in them. Polyphenols are...
5.
Avena P, De Luca A, Chimento A, Nocito M, Sculco S, Padula D, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010877
The aim of this study was to investigate the metabolic changes that occur in adrenocortical cancer (ACC) cells in response to the modulation of Estrogen Related Receptor (ERR)α expression and...
6.
Chimento A, DAmico M, Pezzi V, De Amicis F
Int J Mol Sci
. 2022 Jun;
23(11).
PMID: 35682974
Notch signaling dysregulation encourages breast cancer progression through different mechanisms such as stem cell maintenance, cell proliferation and migration/invasion. Furthermore, Notch is a crucial driver regulating juxtracrine and paracrine communications...
7.
Chimento A, De Luca A, Avena P, De Amicis F, Casaburi I, Sirianni R, et al.
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163166
It is known that estrogen stimulates growth and inhibits apoptosis through estrogen receptor(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence that estrogens can also induce apoptosis,...
8.
Nocito M, De Luca A, Prestia F, Avena P, Padula D, Zavaglia L, et al.
Biomedicines
. 2021 Oct;
9(10).
PMID: 34680593
Curcumin, a main bioactive component of the L. rhizome, is a phenolic compound that exerts a wide range of beneficial effects, acting as an antimicrobial, antioxidant, anti-inflammatory and anticancer agent....
9.
Chimento A, Santarsiero A, Iacopetta D, Ceramella J, De Luca A, Infantino V, et al.
Int J Mol Sci
. 2021 Jun;
22(10).
PMID: 34067547
Resveratrol (RSV) is a natural compound that displays several pharmacological properties, including anti-cancer actions. However, its clinical application is limited because of its low solubility and bioavailability. Here, the antiproliferative...
10.
Chimento A, De Luca A, Nocito M, Sculco S, Avena P, Padula D, et al.
J Cell Mol Med
. 2021 Mar;
25(8):3856-3869.
PMID: 33650791
Adrenocortical cancer (ACC) is a rare tumour with unfavourable prognosis, lacking an effective treatment. This tumour is characterized by IGF-II (insulin-like growth factor II) overproduction, aromatase and ERα (oestrogen receptor...